Progress and challenges in the vaccine-based treatment of head and neck cancers

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Head and neck (HN) cancer represents one of the most challenging diseases because the mortality remains high despite advances in early diagnosis and treatment. Although vaccine-based approaches for the treatment of advanced squamous cell carcinoma of the head and neck have achieved limited clinical success, advances in cancer immunology provide a strong foundation and powerful new tools to guide current attempts to develop effective cancer vaccines. This article reviews what has to be rather what has been done in the field for the development of future vaccines in HN tumours.

Original languageEnglish
Article number69
JournalJournal of Experimental and Clinical Cancer Research
Volume28
Issue number1
DOIs
Publication statusPublished - 2009

Fingerprint

Head and Neck Neoplasms
Vaccines
Cancer Vaccines
Allergy and Immunology
Early Diagnosis
Neoplasms
Neck
Head
Mortality
Carcinoma, squamous cell of head and neck

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

@article{ecdf0ef522f74566a8a8fcc2e4a92bc1,
title = "Progress and challenges in the vaccine-based treatment of head and neck cancers",
abstract = "Head and neck (HN) cancer represents one of the most challenging diseases because the mortality remains high despite advances in early diagnosis and treatment. Although vaccine-based approaches for the treatment of advanced squamous cell carcinoma of the head and neck have achieved limited clinical success, advances in cancer immunology provide a strong foundation and powerful new tools to guide current attempts to develop effective cancer vaccines. This article reviews what has to be rather what has been done in the field for the development of future vaccines in HN tumours.",
author = "Aldo Venuti",
year = "2009",
doi = "10.1186/1756-9966-28-69",
language = "English",
volume = "28",
journal = "Journal of Experimental and Clinical Cancer Research",
issn = "0392-9078",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Progress and challenges in the vaccine-based treatment of head and neck cancers

AU - Venuti, Aldo

PY - 2009

Y1 - 2009

N2 - Head and neck (HN) cancer represents one of the most challenging diseases because the mortality remains high despite advances in early diagnosis and treatment. Although vaccine-based approaches for the treatment of advanced squamous cell carcinoma of the head and neck have achieved limited clinical success, advances in cancer immunology provide a strong foundation and powerful new tools to guide current attempts to develop effective cancer vaccines. This article reviews what has to be rather what has been done in the field for the development of future vaccines in HN tumours.

AB - Head and neck (HN) cancer represents one of the most challenging diseases because the mortality remains high despite advances in early diagnosis and treatment. Although vaccine-based approaches for the treatment of advanced squamous cell carcinoma of the head and neck have achieved limited clinical success, advances in cancer immunology provide a strong foundation and powerful new tools to guide current attempts to develop effective cancer vaccines. This article reviews what has to be rather what has been done in the field for the development of future vaccines in HN tumours.

UR - http://www.scopus.com/inward/record.url?scp=67650757467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650757467&partnerID=8YFLogxK

U2 - 10.1186/1756-9966-28-69

DO - 10.1186/1756-9966-28-69

M3 - Article

VL - 28

JO - Journal of Experimental and Clinical Cancer Research

JF - Journal of Experimental and Clinical Cancer Research

SN - 0392-9078

IS - 1

M1 - 69

ER -